How Can Biopharma Take on Scope 3 Carbon Emissions?

September 5, 2024 EcoVadis EN


When Cytiva recently surveyed the biopharma industry to gain insights into sustainability progress, there was good news and bad news. Companies are succeeding in managing Scope 1 and 2 carbon emissions (Scope 1 covers direct emissions from owned or controlled sources, while Scope 2 covers indirect emissions resulting from the purchase of electricity, steam, heat or cooling)—but when it comes to Scope 3, struggles persist.



Read the full article at: www.genengnews.com

Read more...

About the Author

EcoVadis EN

EcoVadis is a purpose-driven company whose mission is to provide the world's most trusted business sustainability ratings. Businesses of all sizes rely on EcoVadis’ expert intelligence and evidence-based ratings to manage risk and compliance, drive decarbonization, and improve the sustainability performance of their business and value chain. Its AI-powered risk mapping, actionable scorecards, benchmarks, carbon action tools, and insights guide a resilience and improvement journey for environmental, social and ethical practices across 200 industry categories and 175 countries.

Follow on Twitter Follow on Linkedin Visit Website More Content by EcoVadis EN
Previous Article
Packaging designs go all-in on recyclability
Packaging designs go all-in on recyclability

Packaging designs are increasingly prioritising recyclability, from the selection of sustainable materials ...

Next Article
McBride's Surcare cuts plastic with Elopak carton switch
McBride's Surcare cuts plastic with Elopak carton switch

European manufacturer of cleaning and hygiene products McBride has announced a significant step towards sus...